# Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

Study · id `cardio:ct-nct05268094` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05268094](<https://clinicaltrials.gov/study/NCT05268094>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05268094

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT05268094. Randomized; no masking; primary purpose treatment. Start 2022-06-02 (actual); primary completion 2027-09-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT05268094, source copy `cardio:ctgov-nct05268094-2026-01-07`, retrieved 2026-10-26)
- Started: 2022-06-02 (actual) (ClinicalTrials.gov record NCT05268094, source copy `cardio:ctgov-nct05268094-2026-01-07`, retrieved 2026-10-26)
- Primary completion: 2027-09-01 (anticipated) (ClinicalTrials.gov record NCT05268094, source copy `cardio:ctgov-nct05268094-2026-01-07`, retrieved 2026-10-26)
- Completion: 2028-02-29 (anticipated) (ClinicalTrials.gov record NCT05268094, source copy `cardio:ctgov-nct05268094-2026-01-07`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT05268094, source copy `cardio:ctgov-nct05268094-2026-01-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05268094-2026-01-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
- Acronym: COMPASS
- Condition: Congenital Heart Disease in Children
- Intervention (Device): Ductal Arterial Stent
- Intervention (Procedure): Systemic-to-Pulmonary Artery Shunt
- Lead sponsor: Carelon Research
- Lead sponsor class: OTHER
- Collaborator: Pediatric Heart Network
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: Carelon Research (`cardio:org-carelon-research`)

## Provenance

Content hash: 7d911515b12e02b284b8f04b5927938f0ae746d1c4ccb1cec7bc5789353a240c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
